Omeros Corporation
OMER
#6443
Rank
โ‚ฌ0.66 B
Marketcap
9,32ย โ‚ฌ
Share price
-1.63%
Change (1 day)
-15.19%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -โ‚ฌ0.12 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ0.14 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.12 Billion-15.2%
2024 -โ‚ฌ0.14 Billion9.63%
2023 -โ‚ฌ0.13 Billion-9.57%
2022 -โ‚ฌ0.14 Billion-30.65%
2021 -โ‚ฌ0.2 Billion86.28%
2020 -โ‚ฌ0.11 Billion99.45%
2019 -โ‚ฌ53.11 Million-49.91%
2018 -โ‚ฌ0.11 Billion190.77%
2017 -โ‚ฌ36.47 Million-27.96%
2016 -โ‚ฌ50.62 Million-17.61%
2015 -โ‚ฌ61.44 Million1.88%
2014 -โ‚ฌ60.3 Million87.56%
2013 -โ‚ฌ32.15 Million
2011 -โ‚ฌ23.55 Million-8.96%
2010 -โ‚ฌ25.86 Million45.03%
2009 -โ‚ฌ17.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-โ‚ฌ8.16 Million-92.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚ฌ3.32 Million-96.94%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
โ‚ฌ10.17 B-9,490.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.82 B-25,768.33%๐Ÿ‡บ๐Ÿ‡ธ USA